Lung cancer screening and management

Minerva Medica

Volumn 106, Issue 6, 2015, Pages 339-354

  Jones, G S ^a   Baldwin, D R ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Diagnosis; Lung neoplasms; Tomography; X ray computed

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; INCIDENTAL FINDING; LOW RADIATION DOSE COMPUTED TOMOGRAPHY; LUNG CANCER; LUNG NODULE; META ANALYSIS (TOPIC); PATIENT COMPLIANCE; PATIENT PARTICIPATION; PRACTICE GUIDELINE; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC); THORAX RADIOGRAPHY; CANCER STAGING; COST BENEFIT ANALYSIS; EARLY CANCER DIAGNOSIS; ECONOMICS; EVIDENCE BASED MEDICINE; HEALTH; LUNG NEOPLASMS; MASS SCREENING; MORTALITY; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; GLOBAL HEALTH; HUMANS; LUNG NEOPLASMS; MASS CHEST X-RAY; MASS SCREENING; NEOPLASM STAGING; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84962009929     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide 2012 [Internet]. Available from http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx [cited 2015, Nov 25].
2. Eurostat Press Office. 1 in 4 Deaths Caused by Cancer in the EU28. 2014 [Internet] Availavble from http://ec.europa.eu/eurostat/documents/2995521/6131615/3-25112014-BP-EN/aab2c2d3-aed9-430a-a561-e188b8ef49d8 [cited 2015, Feb 10].
3. Who is smoking? [Internet]. Available from [http://www.euro.who.int/en/health-topics/disease-prevention/tobacco/data-and-statistics/who-is-smoking [cited 2015, Nov 25].
4. Walters S, Maringe C, Coleman MP, Peake MD, Butler J, Young N, et al. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007. Thorax 2013, 68:551-64.
5. National Lung Screening Trial Research T, Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, et al. The National Lung Screening Trial: overview and study design. Radiology 2011;258:243-53.
6. Kovalchik SA, Tammemagi M, Berg CD, Caporaso NE, Riley TL, Korch M, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 2013;369:245-54.
7. Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med 2013;159:411-20.
8. Verma V, Beriwal S. Medicare Approves Coverage for Lung Cancer Screening: The Case for Symptomatic Screening. JAMA Oncol 2015;1:1027-8.
9. van Iersel CA, de Koning HJ, Draisma G, Mali WP, Scholten ET, Nackaerts K, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomized lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007;120:868-74.
10. Xu DM, Gietema H, de Koning H, Vernhout R, Nackaerts K, Prokop M, et al. Nodule management protocol of the NELSON randomized lung cancer screening trial. Lung Cancer 2006;54:177-84.
11. van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009;361:2221-9.
12. Baldwin DR, Duffy SW, Wald NJ, Page R, Hansell DM, Field JK. UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomized controlled trial of low-dose CT screening for lung cancer. Thorax 2011;66:308-13.
13. Pastorino U, Rossi M, Rosato V, Marchiano A, Sverzellati N, Morosi C, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 2012;21:308-15.
14. Infante M, Cavuto S, Lutman FR, Brambilla G, Chiesa G, Ceresoli G, et al. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med 2009;180:445-53.
15. Wille MM, Dirksen A, Ashraf H, Saghir Z, Bach KS, Brodersen J, et al. Results of the randomized danish lung cancer screening trial with focus on highrisk profiling. Am J Respir Crit Care Med 2015 [Epub ahead of print].
16. Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, et al. Randomized Study on Early Detection of Lung Cancer with MSCT in Germany: Results of the First 3 Years of Follow-up After Randomization. J Thorac Oncol 2015;10:890-6.
17. Lopes Pegna A, Picozzi G, Mascalchi M, Maria Carozzi F, Carrozzi L, Comin C, et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer 2009;64:34-40.
18. Blanchon T, Brechot JM, Grenier PA, Ferretti GR, Lemarie E, Milleron B, et al. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer 2007;58:50-8.
19. Field JK, Hansell DM, Duffy SW, Baldwin DR. CT screening for lung cancer: countdown to implementation. Lancet Oncol 2013;14:e591-600.
20. Field JK, Smith RA, Aberle DR, Oudkerk M, Baldwin DR, Yankelevitz D, et al. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol 2012;7:10-9.
21. Raji OY, Duffy SW, Agbaje OF, Baker SG, Christiani DC, Cassidy A, et al. Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study. Ann Int Med 2012;157:242-50.
22. Field JK, Baldwin DR, Whynes DK, Devaraj A, Brain KE, Eisen T, et al. United Kingdom Lung Cancer RCT Pilot Screening Trial (UKLS): Baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 2015 [Epub ahead of print].
23. Tammemagi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, et al. Selection criteria for lung-cancer screening. N Engl J Med 2013;368:728-36.
24. Tammemagi MC. Application of risk prediction models to lung cancer screening: a review. J Thorac Imaging 2015;30:88-100.
25. Wilson DO, Weissfeld J. A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh Predictor. Lung Cancer 2015;89:31-7.
26. Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, Barnett MJ, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003;95:470-8.
27. Wilson DO, Leader JK, Fuhrman CR, Reilly JJ, Sciurba FC, Weissfeld JL. Quantitative computed tomography analysis, airflow obstruction, and lung cancer in the pittsburgh lung screening study. J Thorac Oncol 2011;6:1200-5.
28. Ionising radiation: dose comparisons [Internet]. Available from https://www.gov.uk/government/publications/ionising-radiation-dose-comparisons/ionisingradiation-dose-comparisons [cited 2015, Nov 25].
29. de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, et al.: Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 2014, 160:311-320.
30. Sinsuat M, Saita S, Kawata Y, Niki N, Ohmatsu H, Tsuchida T, Kakinuma R, Kusumoto M, Eguchi K, Kaneko M, et al. Influence of slice thickness on diagnoses of pulmonary nodules using low-dose CT: potential dependence of detection and diagnostic agreement on features and location of nodule. Acad Radiol 2011;18:594-604.
31. Lee HY, Goo JM, Lee HJ, Lee CH, Park CM, Park EA, et al. Usefulness of concurrent reading using thinsection and thick-section CT images in subcentimetre solitary pulmonary nodules. Clin Radiol 2009;64:127-32.
32. Fischbach F, Knollmann F, Griesshaber V, Freund T, Akkol E, Felix R. Detection of pulmonary nodules by multislice computed tomography: improved detection rate with reduced slice thickness. Eur Radiol 2003;13:2378-83.
33. Cui Y, Ma D-Q, Liu W-H. Value of multiplanar reconstruction in MSCT in demonstrating the relationship between solitary pulmonary nodule and bronchus. Clin Imaging 2009;33:15-21.
34. Jankowski A, Martinelli T, Timsit JF, Brambilla C, Thony F, Coulomb M, et al. Pulmonary nodule detection on MDCT images: evaluation of diagnostic performance using thin axial images, maximum intensity projections, and computer-assisted detection. Eur Radiol 2007;17:3148-56.
35. Kawel N, Seifert B, Luetolf M, Boehm T. Effect of slab thickness on the CT detection of pulmonary nodules: use of sliding thin-slab maximum intensity projection and volume rendering. AJR Am J Roentgenol 2009;192:1324-9.
36. Matsumoto S, Ohno Y, Yamagata H, Nogami M, Kono A, Sugimura K. Potential contribution of multiplanar reconstruction (MPR) to computer-aided detection of lung nodules on MDCT. Eur J Radiol 2012;81:366-70.
37. Valencia R, Denecke T, Lehmkuhl L, Fischbach F, Felix R, Knollmann F. Value of axial and coronal maximum intensity projection (MIP) images in the detection of pulmonary nodules by multislice spiral CT: comparison with axial 1-mm and 5-mm slices. Eur Radiol 2006;16:325-32.
38. Revel MP, Bissery A, Bienvenu M, Aycard L, Lefort C, Frija G. Are two-dimensional ct measurements of small noncalcified pulmonary nodules reliable? Radiology 2004;231:453-8.
39. Korst RJ, Lee BE, Krinsky GA, Rutledge JR. The utility of automated volumetric growth analysis in a dedicated pulmonary nodule clinic. J Thorac Cardiovasc Surg 2011;142:372-7.
40. Horeweg N, van der Aalst CM, Vliegenthart R, Zhao Y, Xie X, Scholten ET, et al. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J 2013;42:1659-67.
41. Xu DM, van der Zaag-Loonen HJ, Oudkerk M, Wang Y, Vliegenthart R, Scholten ET, et al. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up. Radiology 2009;250:264-72.
42. Horeweg N, Scholten ET, de Jong PA, van der Aalst CM, Weenink C, Lammers JW, et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 2014;15:1342-50.
43. Nair A, Holemans JA, Jones D, Clements L, Baldwin DR, Field JK, et al. Performance of trained radiographers in lung nodule detection: prospective comparison with experienced radiologists in lung cancer screening. Eur Radiol 2015 [Epub ahead of print].
44. Pauli R, Hammond S, Cooke J, Ansell J. Radiographers as film readers in screening mammography: an assessment of competence under test and screening conditions. Br J Radiol 1996;69:10-4.
45. Roos JE, Paik D, Olsen D, Liu EG, Chow LC, Leung AN, et al. Computer-aided detection (CAD) of lung nodules in CT scans: radiologist performance and reading time with incremental CAD assistance. Eur Radiol 2010;20:549-57.
46. Armato ISG, Roy AS, MacMahon H, Li F, Doi K, Sone S, et al. Evaluation of automated lung nodule detection on low-dose computed tomography scans from a lung cancer screening program. Acad Radiol 2005;12:337-46.
47. Godoy MCB, Cooperberg PL, Maizlin ZV, Yuan R, McWilliams A, Lam S, et al. Detection sensitivity of a commercial lung nodule CAD system in a series of pathologically proven lung cancers. J Thorac Imaging 2008;23:1-6.
48. Zhao Y, de Bock GH, Vliegenthart R, van Klaveren RJ, Wang Y, Bogoni L, et al. Performance of computeraided detection of pulmonary nodules in low-dose CT: comparison with double reading by nodule volume. Eur Radiol 2012;22:2076-84.
49. Callister ME, Baldwin DR, Akram AR, Barnard S, Cane P, Draffan J, et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax 2015;70(Suppl 2):ii1-ii54.
50. de Hoop B, van Ginneken B, Gietema H, Prokop M. Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy. Radiology 2012;265:611-6.
51. McWilliams A, Tammemagi MC, Mayo JR, Roberts H, Liu G, Soghrati K, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013;369:910-9.
52. Horeweg N, van Rosmalen J, Heuvelmans MA, van der Aalst CM, Vliegenthart R, Scholten ET, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014;15:1332-41.
53. Kim H, Park CM, Woo S, Lee SM, Lee HJ, Yoo CG, et al. Pure and part-solid pulmonary ground-glass nodules: measurement variability of volume and mass in nodules with a solid portion less than or equal to 5 mm. Radiology 2013;269:585-93.
54. Kim H, Park CM, Lee SM, Lee HJ, Goo JM. A comparison of two commercial volumetry software programs in the analysis of pulmonary ground-glass nodules: segmentation capability and measurement accuracy. Korean J Radiol 2013;14:683-91.
55. Herder GJ, van Tinteren H, Golding RP, Kostense PJ, Comans EF, Smit EF, Hoekstra OS: Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest 2005;128:2490-6.
56. Swensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Int Med 1997;157:849-55.
57. Al-Ameri A, Malhotra P, Thygesen H, Plant PK, Vaidyanathan S, Karthik S, et al. Risk of malignancy in pulmonary nodules: A validation study of four prediction models. Lung Cancer 2015;89:27-30.
58. Henschke CI, Yip R, Yankelevitz DF, Smith JP. International Early Lung Cancer Action Program I: Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2013;158:246-52.
59. Field JK, Oudkerk M, Pedersen JH, Duffy SW. Prospects for population screening and diagnosis of lung cancer. Lancet 2013;382:732-41.
60. van de Wiel JC, Wang Y, Xu DM, van der Zaag-Loonen HJ, van der Jagt EJ, van Klaveren RJ, et al. Neglectable benefit of searching for incidental findings in the Dutch-Belgian lung cancer screening trial (NELSON) using low-dose multidetector CT. Eur Radiol 2007;17:1474-82.
61. Jacobs PC, Prokop M, van der Graaf Y, Gondrie MJ, Janssen KJ, de Koning HJ, et al. Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers. Atherosclerosis 2010;209:455-62.
62. Kucharczyk MJ, Menezes RJ, McGregor A, Paul NS, Roberts HC. Assessing the impact of incidental findings in a lung cancer screening study by using lowdose computed tomography. Can Assoc Radiol J 2011;62:141-5.
63. Jacobs PC, Gondrie MJ, van der Graaf Y, de Koning HJ, Isgum I, van Ginneken B, et al. Coronary artery calcium can predict all-cause mortality and cardiovascular events on low-dose CT screening for lung cancer. AJR Am J Roentgenol 2012;198:505-11.
64. Kim YK, Sung YM, Cho SH, Park YN, Choi HY. Reliability analysis of visual ranking of coronary artery calcification on low-dose CT of the thorax for lung cancer screening: comparison with ECG-gated calcium scoring CT. Int J Cardiovasc Imaging 2014;30(Suppl 2):81-7.
65. Damiani G, Federico B, Basso D, Ronconi A, Bianchi CB, Anzellotti GM, et al. Socioeconomic disparities in the uptake of breast and cervical cancer screening in Italy: a cross sectional study. BMC Public Health 2012;12:99.
66. Shankleman J, Massat NJ, Khagram L, Ariyanayagam S, Garner A, Khatoon S, et al. Evaluation of a service intervention to improve awareness and uptake of bowel cancer screening in ethnically-diverse areas. Br J Cancer 2014;111:1440-7.
67. McRonald FE, Yadegarfar G, Baldwin DR, Devaraj A, Brain KE, Eisen T, et al. The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening. Cancer Prev Res (Phila) 2014;7:362-71.
68. Camilloni L, Ferroni E, Cendales BJ, Pezzarossi A, Furnari G, Borgia P, et al. Methods to increase participation Working G: Methods to increase participation in organized screening programs: a systematic review. BMC Public Health 2013;13:464.
69. Maheswaran R, Pearson T, Jordan H, Black D. Socioeconomic deprivation, travel distance, location of service, and uptake of breast cancer screening in North Derbyshire, UK. J Epidemiol Community Health 2006;60:208-12.
70. Patz EF, Jr., Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemagi MC, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 2014;174:269-74.
71. van den Bergh KA, Essink-Bot ML, Borsboom GJ, Scholten ET, van Klaveren RJ, de Koning HJ. Longterm effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J 2011;38:154-61.
72. Rasmussen JF, Siersma V, Pedersen JH, Brodersen J. Psychosocial consequences in the Danish randomized controlled lung cancer screening trial (DLCST). Lung Cancer 2015;87:65-72.
73. Villanti AC, Jiang Y, Abrams DB, Pyenson BS. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions. PLoS One 2013;8:e71379.
74. Black WC, Keeler EB, Soneji SS. Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med 2015;372:388.
75. McMahon PM, Kong CY, Bouzan C, Weinstein MC, Cipriano LE, Tramontano AC, et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol 2011;6:1841-48.
76. Vertinsky T, Forster B. Prevalence of eye strain among radiologists: influence of viewing variables on symptoms. AJR Am J Roentgenol 2005;184:681-6.